Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun 10:4:64.
doi: 10.3389/fneur.2013.00064. eCollection 2013.

The management of orthostatic hypotension in Parkinson's disease

Affiliations

The management of orthostatic hypotension in Parkinson's disease

Alvaro Sánchez-Ferro et al. Front Neurol. .

Abstract

Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson's disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD.

Keywords: L-DOPA; Parkinson’s disease; continuous dopaminergic stimulation; dopamine agonists; orthostatic hypotension; treatment.

PubMed Disclaimer

References

    1. Abassi Z. A., Binah O., Youdim M. B. (2004). Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline. Br. J. Pharmacol. 143, 371–378 10.1038/sj.bjp.0705962 - DOI - PMC - PubMed
    1. Allcock L. M., Kenny R. A., Burn D. J. (2006). Clinical phenotype of subjects with Parkinson’s disease and orthostatic hypotension: autonomic symptom and demographic comparison. Mov. Disord. 21, 1851–1855 10.1002/mds.20996 - DOI - PubMed
    1. Allcock L. M., Ullyart K., Kenny R. A., Burn D. J. (2004). Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson’s disease. J. Neurol. Neurosurg. Psychiatr. 75, 1470–1471 10.1136/jnnp.2003.029413 - DOI - PMC - PubMed
    1. Arbogast S. D., Alshekhlee A., Hussain Z., McNeeley K., Chelimsky T. C. (2009). Hypotension unawareness in profound orthostatic hypotension. Am. J. Med. 122, 574–580 10.1016/j.amjmed.2008.10.040 - DOI - PubMed
    1. Awerbuch G. I., Sandyk R. (1992). Autonomic functions in the early stages of Parkinson’s disease. Int. J. Neurosci. 64, 7–14 10.3109/00207459209000530 - DOI - PubMed

LinkOut - more resources